Saab AB/ SE0000112385 /
2024-03-28 12:54:59 PM | Chg. -13.40 | Volume | Bid12:55:00 PM | Ask12:55:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
949.60SEK | -1.39% | 75,609 Turnover: 33.85 mill. |
-Bid Size: - | -Ask Size: - | 125.81 bill.SEK | 0.56% | 57.31 |
GlobeNewswire
2023-12-19
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
2023-11-29
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
2023-11-13
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
2023-11-03
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...
GlobeNewswire
2023-10-05
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of M...
GlobeNewswire
2023-09-05
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for...
GlobeNewswire
2022-03-23
Fashion takes center-stage in the Metaverse at Decentraland’s Metaverse Fashion Week
GlobeNewswire
2022-02-25
New York, Paris, Milan, Decentraland; Global Fashion Goes Virtual with the World’s Biggest Metaverse...
GlobeNewswire
2022-02-02
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s...
GlobeNewswire
2021-12-14
Leading Digital Wholesale Platform JOOR Enters Bridal Category At Time Of Unprecedented Demand